Re: [IAC#RG] Some good news on vaccine front

Anyone knows why "rejected for use in the USA"?

On Mon, 17 May 2021, 15:47 Sandeep Nagpal, <indiaresists@lists.riseup.net> wrote:

A very good strategy to make (secret) profits... export price of USD 3.75 and reimport price of USD 11.83...

On Mon, May 17, 2021 at 4:51 AM Bikash Bhattacharya <indiaresists@lists.riseup.net> wrote:

Friends

Finally, a good news on the vaccine front.

The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.

The prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.

This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.

Bikash Bhattacharya

Member Covid Task Force

Laghu Udyog Bharti (WB)

Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

Re: [IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna’s research

So this drug has been in experimentation for very long in INMAS-DRDO. Even many years before COVID came into existence, DRDO was using it as an radioprotective drug against tumor cells. 

Check the author list, after Acharya Balkrishna, another name is Dr. Pallavi Thakur, who is an ex-INMAS fellow. Also, you may find the research articles published by INMAS in the given link.

https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=2+deoxy+d+glucose+INMAS&btnG=.  Patanjali has done some simulation work on the effectiveness of 2-Deoxy D Glucose, but not actual clinical trials. 

 

Kanishka Sharma, Ph.D.

---

From: indiaresists-request@lists.riseup.net <indiaresists-request@lists.riseup.net> on behalf of Pankaj Jangid <pankaj@codeisgreat.org>
Sent: Friday, May 14, 2021 10:25 AM
To: indiaresists@lists.riseup.net <indiaresists@lists.riseup.net>
Subject: [IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna's research

 

I started to dig about this new drug 2-DG, which was launched last week
by DRDO and Dr. Reddy's. This drug is claimed to reduce the oxygen
demand by a body infected with covid-19.

Reading more on this, I found that this is actually based on a research
paper by Acharya Balkrishna et al. of Patanjali Ayurveda. Here is the
original paper published on the aggregator ResearchGate:

https://www.researchgate.net/publication/340332773_Glucose_antimetabolite_2-Deoxy-D-Glucose_and_its_derivative_as_promising_candidates_for_tackling_COVID-19_Insights_derived_from_in_silico_docking_and_molecular_simulations

--
Regards,
Pankaj Jangid

Re: [IAC#RG] Some good news on vaccine front

A very good strategy to make (secret) profits... export price of USD 3.75 and reimport price of USD 11.83...

On Mon, May 17, 2021 at 4:51 AM Bikash Bhattacharya <indiaresists@lists.riseup.net> wrote:

Friends

Finally, a good news on the vaccine front.

The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.

The prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.

This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.

Bikash Bhattacharya

Member Covid Task Force

Laghu Udyog Bharti (WB)

Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

Re: [IAC#RG] Another fake COVID-19 drug gets approval from CORRUPT DCGI

Dear Ms. Kotwal and  Dr. Rajan

Although the 2-DG molecules have been used extensively for cancer treatment it still lacks approval from the regulators as an anti-cancer drug for the reason that the 2-DG's theory of glycolysis inhibition destroying malignant cells is still unproven on humans.

It is well known by now, the the DRDO is a completely useless body packed with the most stupid and otherwise unemployable scientists ever assembled in one organsiation. No private company worth the name would hire these DRDO morons, Patanjali being the notable exception so as to tomtom that Baba-no-Swami-no-Rishi Ramdev (or his homosexual buddy) invented 2-DG.

Dr. Rajan does a great disservice to our members by not linking to the Hindu article he referred to which exposed 2-DG is a FAKE DRUG,

There is also no doubt that 2-DG is a FAKE DRUG for COVID treatment, and it's as fake as that Nepali billionaire "inter"-fail rogue "Acharya" Balkrishna's medical / research qualifications are.

From these kinds of dubious approvals, it is also undeniable that present DCGI  Dr. V.G Somani (probably a Gujarati like the rest of Modi's key appointees) is a corrupt and pliable rubber stamp Drugs regulator, handpicked by Modi to carry out the final scams of a Govt on its way out.

NB: Anyone promoting fake COVID drugs / cures / quacks on this mailing list will be unsubscribed without notice.

RS Dalvi

List Administrator

Camp: Germany (Europe)

On Sat, May 15, 2021 at 11:20 PM Swati Kotwal <indiaresists@lists.riseup.net> wrote:

Dear all, 

Thanks to Dr Rajan for his reply. There is lot of research on 2-DG use in cancer treatment. Considering the fact that there is no proven and 100% effective drug against COVID, research community is testing the efficacy of various antiviral n other drugs to treat COVID (repurposed drug). Kudos to DRDO and let us hope that the drug is successful. 

Dr Swati Kotwal (Retd)

University Department of Biochemistry RTMNU Nagpur

Sent from my iPhone

On 14-May-2021, at 8:17 PM, m.g.r. rajan <mgr_rajan@hotmail.com> wrote:



I too searched literature on 2-DG and found this pre-print (meaning not peer-reviewed) publication from Patanjali on Researchgate website. It is a theoretical study based on computer simulation. One of the co-authors is an ex-Director of a DRDO-Institute. 

2-DG is a long-known molecule, having been developed as an anti-cancer metabolite. The present group has boldly tested it in Covid-19 patients and have shown favourable results and have obtained DCGI-approval. To that extent the work done is novel. It remains to be seen how it works out in field use. The side effects 

Incidentally, DRDO-INMAS has published papers using this molecule more than a decade ago as an adjuvant in radiation therapy for a few cancers. 

However, some experts have expressed reservations against 2-DG for treating covid-19 patients as expressed in The Hindu. 

There is a Swedish company that announced on March 11th, a nasal spray containing 2-DG.

Dr. Rajan

---

From: indiaresists-request@lists.riseup.net <indiaresists-request@lists.riseup.net> on behalf of Pankaj Jangid <pankaj@codeisgreat.org>
Sent: Friday, May 14, 2021 10:25 AM
To: indiaresists@lists.riseup.net <indiaresists@lists.riseup.net>
Subject: [IAC#RG] New DRDO Drug 2-DG is based on Acharya Balkrishna's research

 

I started to dig about this new drug 2-DG, which was launched last week
by DRDO and Dr. Reddy's. This drug is claimed to reduce the oxygen
demand by a body infected with covid-19.

Reading more on this, I found that this is actually based on a research
paper by Acharya Balkrishna et al. of Patanjali Ayurveda. Here is the
original paper published on the aggregator ResearchGate:

https://na01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.researchgate.net%2Fpublication%2F340332773_Glucose_antimetabolite_2-Deoxy-D-Glucose_and_its_derivative_as_promising_candidates_for_tackling_COVID-19_Insights_derived_from_in_silico_docking_and_molecular_simulations&amp;data=04%7C01%7C%7Caac01eb4e3cf44a4a7fc08d916bb719d%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637565816615923917%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=a8ahOYlOxOBv6QoAL4ICihR09l%2Fa2tDD%2FMf82uU95SE%3D&amp;reserved=0

--
Regards,
Pankaj Jangid

Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in

[IAC#RG] India's top virologist quits after complaining that scientists are not taken seriously

India's Dr. Fauci has quit unable to take the daily humiliations and insults being heaped on Indian scientists by the pliable sycophants Narendra Modi has installed in every regulatory medical agency or Ministry which is dealing with the COVID-19 2nd wave crisis and where "scientists were facing stubborn resistance to evidence-based policy-making".

Shahid Jameel quits as head of virus genome sequencing group

So humiliated was Dr. Jameel that he penned an article in the New York Times which has now been blocked in India by the censors whiv I reproduce below in public interest

How India Can Survive the Virus

Vaccines alone won't save the country.

May 13, 2021

By Shahid Jameel

A woman getting the Covid-19 vaccine in Mumbai, India. Credit...Punit Paranjpe/Agence France-Presse — Getty Images
Dr. Jameel is a virologist.

NEW DELHI — As of Tuesday, India had over 23 million reported cases of Covid-19 and more than 254,000 deaths. The real numbers may be much higher, as the country reported an average of more than 380,000 new cases per day in the past week.

As a virologist, I have closely followed the outbreak and vaccine development over the past year. I also chair the Scientific Advisory Group for the Indian SARS-CoV2 Consortium on Genomics, set up by the Indian government in January as a grouping of national laboratories that use genetic sequencing to track the emergence and circulation of viral variants. My observations are that more infectious variants have been spreading, and to mitigate future waves, India should vaccinate with far more than the two million daily doses now.

In India the virus was mutating around the new year to become more infectious, more transmissible and better able to evade pre-existing immunity. Sequencing data now tells us that two variants that fueled the second wave are B.1.617, first found in India in December, which spread through mass events; and B.1.1.7, first identified in Britain, which arrived in India with international travelers starting in January. The B.1.617 variant has now become the most widespread in India.

On Monday the World Health Organization designated B.1.617 a variant of concern. When tested in hamsters, which are reasonable models for human infection and disease, B.1.617 produced higher amounts of virus and more lung lesions compared with the parent B.1 virus. Global data shows the B.1.617 variant to be diversifying into three sub-lineages. In a preliminary report posted on Sunday, British and Indian scientists found the B.1.617.2 variant in vaccine breakthrough infections in a Delhi hospital.

On Monday, American researchers reported the B.1.617.1 variant to be neutralized with reduced efficiency by serums from recovered Covid-19 patients and those vaccinated with the Pfizer and Moderna vaccines. Indian researchers reported similar findings in a preliminary report on April 23.

With these variants circulating through India's still mostly unvaccinated population, public health officials here are trying to determine when the second wave might peak, how big it will be and when it will end.

The estimates vary widely. The Supermodel Group, preferred by the Indian government, estimated cases to have peaked at about 380,000 cases per day in the first week of May. The simulation model by the Indian Scientists Response to COVID-19, a voluntary group of scientists, predicts that daily cases will reach a peak sometime in mid-May, but it forecasts a much higher peak, about 500,000 to 600,000 daily cases. The COV-IND-19 Study Group at the University of Michigan predicts a peak by mid-May with about 800,000 to one million daily cases.

All models predict India's second wave to last until July or August, ending with about 35 million confirmed cases and possibly 500 million estimated infections. That would still leave millions of susceptible people in India. The timing and scale of the third wave would depend on the proportion of vaccinated people, whether newer variants emerge and whether India can avoid additional superspreader events, like large weddings and religious festivals.

What worries me is that we may not even be able to measure the peak cases accurately. Data show that testing is increasing at a far slower rate than cases. In this scenario, numbers will reach a plateau — not because case numbers have stopped rising but because testing capacity will be tapped out. The national average test positivity rate is over 22 percent, but several states have rates that are, alarmingly, even higher — including Goa at 46.3 percent and Uttarakhand, which hosted the Kumbh festival, at 36.5 percent. "India will have a manufactured peak of about 500,000 daily cases by mid-May," argued Rijo M. John, a health economist.

Vaccines remain one of the most effective public health tools, and vaccination with speed is shown to significantly reduce the spread of the coronavirus. India started its vaccination drive in mid-January with a sensible plan to vaccinate 300 million people in phases — health care workers, frontline workers and then people above 60 years of age or above 45 years with comorbidities. And as a leading supplier of vaccines worldwide — India supplies about 40 percent of all the world's vaccines — two Indian companies, Serum Institute of India and Bharat Biotech, were well positioned to execute.

But by mid-March only 15 million doses had been delivered, covering a mere 1 percent of India's population. The vaccination drive was hobbled by messages from Indian leadership that the country had conquered the virus and by news from Europe associating fatal blood clots with the AstraZeneca vaccine, which remains the mainstay of India's vaccination rollout.

When the second wave arrived, only 33 million people, about 2.4 percent of the population, had received one dose and seven million people had received both doses. On May 1, vaccination opened for everyone older than 18 years, but many states have reported shortages and the pace of vaccination has slowed down. Local supplies are expected to stabilize by July, but their low penetration cannot reverse the current wave of infection and death in India.

Covid-19 vaccines mitigate disease, but they may not prevent infection, especially when transmission rates are as high as they are now. Though good data is lacking, variant viruses with evasion potential may also have a role in "breakthrough" infections in vaccinated people.

The immediate need is to reduce spread by increased testing and isolation of people who test positive. Several Indian states are under lockdown. This would "flatten the curve," allowing health care facilities and supplies to regroup. Rapidly enhancing the health care infrastructure will also save lives. India should increase available hospital beds by setting up temporary facilities, mobilize retired doctors and nurses, and strengthen the supply chain for critical medicines and oxygen.

At the same time, India cannot allow the pace of vaccinations to slow. It must vaccinate at scale now, aiming to deliver 7.5 million to 10 million doses every day. This will require enhancing vaccine supplies and doubling delivery points. There are only about 50,000 sites where Indians can get vaccines right now; we need many more. Since only 3 percent of these delivery points are in the private sector, this is where capacity can be added.

All of these measures have wide support among my fellow scientists in India. But they are facing stubborn resistance to evidence-based policymaking. On April 30, over 800 Indian scientists appealed to the prime minister, demanding access to the data that could help them further study, predict and curb this virus.

Decision-making based on data is yet another casualty, as the pandemic in India has spun out of control. The human cost we are enduring will leave a permanent scar.

Shahid Jameel is a virologist and director of the Trivedi School of Biosciences at Ashoka University in Sonipat, India.

[IAC#RG] Some good news on vaccine front

Friends

Finally, a good news on the vaccine front.

The USA has agreed to sell 38 million vials out of the 62 million vials unused AstraZeneca (ie. COVISHIELD equivalent) vaccines to India which were rejected for use in the USA and are lying there since past 2 months. All these 38 million vials were manufactured in India and contain enough vaccine for 10 doses per vial so about 170 million persons can be vaccinated in the next 2 weeks after the vials begin arriving. It will be especially useful for vaccination by corporations and industries as the nation needs to keep the economy going at all costs.

The prices for each COVISHIELD dose will be US$ 11.83 (i.e. estimated approx Rs. 800 per shot in a State govt hospital and Rs.1,800 in a private hospital for 1 dose). These vials were exported at equivalent US$ 3.75 for each 0.5 ml dose from India by Serum India, Pune.

This is a wonderful achievement brought about by Hon'ble Prime Minister's direct talks with USA President Joseph Biden, as otherwise all the State govt global tenders under revised vaccine policy were being L1'd by Chinese vaccine manufacturers like Sinopharm which are the low efficiency vaccines.

Bikash Bhattacharya

Member Covid Task Force

Laghu Udyog Bharti (WB)

Re: [IAC#RG] BILL GATES TO BE TRIED AS WAR CRIMINAL FOR GENOCIDE EXCEEDING ADOLF HITLER’S

Dear Sh Purohit

Logins to the private HRA channels are a privilege, one which was accorded to you as a journalist to access the recent Wikileak Annexures.

Our private documents are not meant to be publicly disclosed, especially since the Bill Gates vaccine mafias routinely tarnish their opponents as anti-vaxxers / discredited conspiracy theorists or by tagging them with lunatics like Robert F Kennedy Jr., Erin Elizabeth and the like who deliberately spread unscientific, irrational and devoid of factual basis pseudo-science about microchips, 5G etc.

IAC#RG is only one of the many public information channels HRA uses and very few subscribers here are actually HRA members.

RS Dalvi

List Administrator

On Sun, May 16, 2021 at 4:37 AM Swapnil Purohit <indiaresists@lists.riseup.net> wrote:

BILL GATES TO BE TRIED AS WAR CRIMINAL FOR GENOCIDE EXCEEDING ADOLF HITLER'S

Access  : via LOGIN
Source  : WIKILEAKS v2.1
Secrecy  : Top Secret Z2 level and above

The Hindustan Republican Army, estd. 1924, on behalf of all true Hindustanis (but not on behalf of their present illegal and puppet governments) stands in collective agreement with our fraternal global revolutionary movements which have conclusively established that the USA based capitalist Mr. William Henry Gates III is the mastermind behind the international conspiracy to massacre, by bio-terrorism and for satisfying his corporate greed and megalomania, millions of innocent victims everywhere, including pregnant mothers and unborn children, for which he cannot be forgiven and so must be brought to justice before an international people's revolutionary tribunal along with his fellow conspirators.

In as much as Hindustan is concerned, The WIKILEAKS has described in soon to be leaked official intelligence documents that the aforesaid William Henry Gates III undertook the following preparatory acts in furtherance of his global conspiracies:-

1. Since 2006 began systematically corrupting key persons in major political parties in Indian administered Hindustan [Ann: A-1]
2. Since 2006 began systematically co-opting key persons in certain NGOs connected with DFID and/or Ford Foundation and/or Wikimedia Foundation [Ann: A-2]
3. Since 2007 effectively took over the Public Health Foundation of India [Ann: A3]
4. Since 2007 began systematically co-opting key bureaucrats in Government Ministries and their missions vital to hs plan for global genocide [Ann: A4]
5. Since 20009 effectively financed and took over the Indian National Congress party [Ann: A5]]
6. Since 2011 effectively dumped INC Party and switched his favor to th…. more

Post: "indiaresists@lists.riseup.net"
Exit: "indiaresists-unsubscribe@lists.riseup.net"
Quit: "https://lists.riseup.net/www/signoff/indiaresists"
Help: https://help.riseup.net/en/list-user
WWW : http://indiaagainstcorruption.net.in